Clinical endpoints in allergen immunotherapy: State of the art 2022

被引：3
|
作者：
van Wijk, R. Gerth [1 ,4 ]
Klimek, L. [2 ]
Pfaar, O. [3 ]
机构：
[1] Erasmus MC, Dept Internal Med, Sect Allergol & Clin Immunol, Rotterdam, Netherlands
[2] Zent Rhinol & Allergol, Wiesbaden, Germany
[3] Philipps Univ Marburg, Univ Klinikum Marburg, Sekt Rhinol & Allergie, Klin Hals Nasen Ohren Heilkunde Kopf & Hals Chirur, Marburg, Germany
[4] Erasmus MC, Abt Allergol klin Immunol, Abt Innere Med, Rotterdam, Netherlands
来源：
ALLERGOLOGIE | 2023年 / 46卷 / 03期
关键词：
allergen immunotherapy; endpoints; rhinitis; asthma; real-life studies; cost-effectiveness; ASTHMA; RHINOCONJUNCTIVITIS; EFFICACY; RHINITIS; ADULTS; TRIAL;
D O I：
10.5414/ALX02334E
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
110 years after the classical study by Noon, numerous studies have confirmed the efficacy of allergen immunotherapy. A variety of clinical endpoints have been used in these trials. This review gives an overview of clinical endpoints for randomized clini-cal trials on allergen immunotherapy (AIT) in rhinitis and asthma. In addition, real-life studies have been carried out with the same kind of endpoints. In general, AIT studies are characterized by a lack of standardized and validated outcome measures. For allergic rhinoconjunctivitis, digital tools have been developed to monitor patients. Such tools are particularly useful to obtain real-world evidence for AIT. Finally, well-accepted out-come measures are available for cost-effec-tiveness studies.
引用
收藏
页码：184 / 192
页数：9
相关论文
共 50 条
  • [31] Placebo effects in allergen immunotherapy-An EAACI Task Force Position Paper
    Pfaar, Oliver
    Agache, Ioana
    Bergmann, Karl-Christian
    Bindslev-Jensen, Carsten
    Bousquet, Jean
    Creticos, Peter S.
    Devillier, Philippe
    Durham, Stephen R.
    Hellings, Peter
    Kaul, Susanne
    Kleine-Tebbe, Joerg
    Klimek, Ludger
    Jacobsen, Lars
    Jutel, Marek
    Muraro, Antonella
    Papadopoulos, Nikolaos G.
    Rief, Winfried
    Scadding, Glenis K.
    Schedlowski, Manfred
    Shamji, Mohamed H.
    Sturm, Gunter
    van Ree, Ronald
    Vidal, Carmen
    Vieths, Stefan
    Wedi, Bettina
    Gerth van Wijk, Roy
    Frew, Anthony J.
    ALLERGY, 2021, 76 (03) : 629 - 647
  • [32] Is Clinical Tolerance Possible after Allergen Immunotherapy?
    Moran, Timothy P.
    Burks, A. Wesley
    CURRENT ALLERGY AND ASTHMA REPORTS, 2015, 15 (05)
  • [33] Efficacy of allergen immunotherapy in reducing the likelihood of developing new allergen sensitizations: a systematic review
    Di Bona, D.
    Plaia, A.
    Leto-Barone, M. S.
    La Piana, S.
    Macchia, L.
    Di Lorenzo, G.
    ALLERGY, 2017, 72 (05) : 691 - 704
  • [34] European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): a real-life clinical assessment
    Calderon, M. A.
    Vidal, C.
    Rodriguez del Rio, P.
    Just, J.
    Pfaar, O.
    Tabar, A. I.
    Sanchez-Machin, I.
    Bubel, P.
    Borja, J.
    Eberle, P.
    Reiber, R.
    Bouvier, M.
    Lepelliez, A.
    Klimek, L.
    Demoly, P.
    ALLERGY, 2017, 72 (03) : 462 - 472
  • [35] Allergen immunotherapy: The growing role of observational and randomized trial "Real-World Evidence"
    Paoletti, Giovanni
    Di Bona, Danilo
    Chu, Derek K.
    Firinu, Davide
    Heffler, Enrico
    Agache, Ioana
    Jutel, Marek
    Klimek, Ludger
    Pfaar, Oliver
    Moesges, Ralph
    DunnGalvin, Audrey
    Genuneit, Jon
    Hoffmann, Hans Jurgen
    Canonica, Giorgio Walter
    ALLERGY, 2021, 76 (09) : 2663 - 2672
  • [36] Allergen immunotherapy for allergic asthma: The future seems bright
    Diamant, Zuzana
    van Maaren, Maurits
    Muraro, Antonella
    Jesenak, Milos
    Striz, Ilja
    RESPIRATORY MEDICINE, 2023, 210
  • [37] Grass pollen allergen immunotherapy: Safety and efficacy profile
    Daboussi, S.
    Chaabane, M.
    Mhamdi, S.
    Saidane, A.
    Aichaouia, C.
    Ben Dhia, I. E.
    Toujani, S.
    Moatemri, Z.
    REVUE FRANCAISE D ALLERGOLOGIE, 2024, 64 (01):
  • [38] Fatalities following allergen immunotherapy
    Andrea T. Borchers
    Carl L. Keen
    M. Eric Gershwin
    Clinical Reviews in Allergy & Immunology, 2004, 27 : 147 - 158
  • [39] Preventive Effect of Allergen Immunotherapy on Asthma and New Sensitizations
    Gradman, Josefine
    Halken, Susanne
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (05) : 1813 - 1817
  • [40] Allergen immunotherapy using NPP: Perspectives for the treatment and prevention of respiratory allergies; the case of pollinosis
    Caimmi, D.
    Demoly, P.
    REVUE FRANCAISE D ALLERGOLOGIE, 2019, 59 (08): : 617 - 623
12345